Novartis Investigative Site

KwaDukuza, KwaZulu-Natal 4449

0 studies enrolling now · 1 studies all time

What they study most

Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling